Home > Healthcare > Medical Devices > Medical Supplies > MRI Contrast Media Market
MRI Contrast Media Market size was valued USD 1.6 billion in 2023 and is expected to grow at a CAGR of 4.6% between 2024 and 2032. The market growth is driven by the growing prevalence of chronic diseases, rising demand for early diagnosis, and increased R&D investment and activities.<
As reported by the American Cancer Society projected figures for new cancer cases and deaths in 2022 indicate an estimated 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the U.S. alone. Thus, rise in cancer/oncology cases is expected to spur the demand for early diagnosis.
MRI contrast media, also known as contrast agents, are imaging agents or the substances injected to enhance the visibility of the tissues or organs during MRI procedure. These agents contain the magnetism properties that alter the magnetic resonance properties of surrounding tissues, providing clearer and more detailed images. MRI contrast media assist in visualizing and characterizing abnormalities like tumors, inflammation, and vascular conditions during MRI scans with enhanced diagnostic precision.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
MRI Contrast Media Market Size in 2023: | USD 1.6 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 4.6% |
2032 Value Projection: | USD 2.5 Billion |
Historical Data for: | 2018 to 2023 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 316 |
Segments covered: | Product, Type, Application, End-use, & Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|